Suven Life shares gain 4.5% as its facility completes USFDA inspection

New Delhi: Shares of Suven Life Sciences today rose by 4.5 per cent after the company said its Pashamylaram facility near Hyderabad has undergone successful inspection by the US health regulator.

The stock jumped 4.55 per cent to close at Rs 189.50 on BSE. Intra-day, it gained 5.93 per cent to Rs 192.

At NSE, shares of the company rose by 4.54 per cent to close at Rs 189.75.

In terms of equity volume, 1.61 lakh shares of the company were traded on BSE and over 11 lakh shares changed hands at NSE during the day.

The facility has undergone renewal inspection from February 5-18 by the United States Food and Drug Administration (USFDA), Suven Life Sciences said in a BSE filing.

The plant is considered to be in an acceptable state of compliance with regards to current good manufacturing practices (CGMP) and the agency has issued an Establishment Inspection Report (EIR) for the facility, it added.